How Pharma Executives View Future Business Travel
Source: Life Science Leader
By Rob Wright and Dan Schell
In May 2021, Industry Standard Research (ISR) conducted a web-based quantitative survey of 154 pharmaceutical/biotech industry participants. The goals of the study included:
- understanding the barriers to restarting business travel
- assessing comfort level with traveling for business in the wake of the pandemic
- predicting when return to in-person events will occur.
access the Magazine Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader